Paul Knight
Stock Analyst at Keybanc
(2.33)
# 2,593
Out of 5,124 analysts
140
Total ratings
45.69%
Success rate
-2.06%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $579.45 | +29.43% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $275.14 | +27.21% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $6.10 | +145.90% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $8.18 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $121.96 | +80.39% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.60 | +56.25% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $106.14 | +27.19% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.67 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $58.81 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $379.83 | +21.11% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $1.28 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.90 | +175.86% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $96.75 | +49.87% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $207.81 | +102.11% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $103.67 | +121.86% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $24.18 | +36.48% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $38.90 | -7.46% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $228.92 | +35.42% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $163.86 | +34.26% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $20.12 | +83.90% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.25 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.80 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $136.07 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $33.26 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.46 | +249.04% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $199.48 | +50.39% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $225.41 | +10.91% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $122.04 | +261.36% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $142.67 | +65.42% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $81.96 | +20.79% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.23 | +389.76% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $42.10 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $78.50 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $131.16 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $579.45
Upside: +29.43%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $275.14
Upside: +27.21%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $6.10
Upside: +145.90%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $8.18
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $121.96
Upside: +80.39%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.60
Upside: +56.25%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $106.14
Upside: +27.19%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.67
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $58.81
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $379.83
Upside: +21.11%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.28
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.90
Upside: +175.86%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $96.75
Upside: +49.87%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $207.81
Upside: +102.11%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $103.67
Upside: +121.86%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $24.18
Upside: +36.48%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $38.90
Upside: -7.46%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $228.92
Upside: +35.42%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $163.86
Upside: +34.26%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $20.12
Upside: +83.90%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.25
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.80
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $136.07
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $33.26
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.46
Upside: +249.04%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $199.48
Upside: +50.39%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $225.41
Upside: +10.91%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $122.04
Upside: +261.36%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $142.67
Upside: +65.42%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $81.96
Upside: +20.79%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.23
Upside: +389.76%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $42.10
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $78.50
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $131.16
Upside: -